Halted Trials Raise New Safety Questions About 'Rushed' COVID-19 Vaccines

"Safety is difficult to know,”

By Tyler Durden: In the interest of "transparency", Pfizer CEO Dr. Albert Bourlas released a statement on Friday outlining the timeline for when its experimental COVID-19 vaccine might be ready for approval for regular, non-emergency use. Much to Trump's chagrin, CEO Dr. Albert Bourla said the earlier the company expects to apply for an emergency-use approval from the FDA would be the third week of November, after the election has come and gone.

The news capped off what was a busy week for vaccine news, which started Monday night with reports that Phase 3 trials for Johnson & Johnson's COVID-19 vaccine have been paused after a participant came down with an "unspecified" illness.

While JNJ executives insisted their vaccine candidate likely wasn't the cause, they brought in investigators and are now working to get the trial going again as quickly as possible. 

Reaching Joe Normie

Computing Forever

The Deep Critical Thinker...

The deep critical thinker has become the misfit of the world, this is not a coincidence. To maintain order and control you must isolate the intellectual, the sage, the philosopher, the savant before their ideas awaken people. This will cause a mental implosion from lack of thought stimulating conversations and interactions with others which will lead to their demise. That is one of the greatest tragedies of our time, the unwelcomed thinker who’s brilliance will never be known. - Carl Jung